SLC2A1 and glioblastoma: Fasentin, an inhibitor of GLUT1 and CR-42-24, colchicine derivative and inhibitor of tubulin were studied to demonstrate their association in the mesenchymal subtyped glioblastoma stem cells GSC33 and GSC28.